pharma · Chronic Lymphocytic Leukaemia (CLL)
Servier Australia
Servier Laboratories (Aust.) Pty.
Servier Laboratories (Aust.) is a pharma organization headquartered in AU. Primary therapeutic focus areas include Chronic Lymphocytic Leukaemia (CLL). NovaPharmaNews links 1 clinical program(s), 7 drug profile(s), and 0
Melbourne, AU HQ
1954 Founded
11 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Founded
- 1954
- Employees
- 11
- Programs
- 1
- Drugs
- 7
- Patents
- 0
S 55746
Phase 1 · small molecule · Chronic Lymphocytic Leukaemia (CLL)
S 55746 for Chronic Lymphocytic Leukaemia (CLL) is a Phase 1 program (small_molecule) at Servier Laboratories (Aust.) Pty. with 1 ClinicalTrials.gov record(s).
Internal code CL1-55746-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Servier Laboratories (Aust.) Pty.
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Chronic Lymphocytic Leukaemia (CLL)
- Status
- completed
- Trials
- 1